Access all areas: improving your medtech market access strategy
This article was originally published in Clinica
Prof Brian D Smith reveals the characteristics that differentiate strong market access strategies from the weak ones
You may also be interested in...
The pharma industry is experiencing an explosion of new business models, more numerous and specialized than we're used to. Companies need to pick the right model and adapt faster and better than their competitors. Part 3 in a series from Brian Smith's new book, Darwin's Medicine.
Where is our industry headed? Exactly where it is being pushed by what Charles Darwin called "immeasurably superior forces." Part 2 in a series from Brian Smith's new book, Darwin's Medicine.
In his forthcoming book, Darwin’s Medicine, Brian Smith argues that the emergence of new business models in the life science industry is explained by Darwin’s brilliant idea.